Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
The DOI matches its Crossref record; 253 of the 253 references it cites were found in a registry or an index.
Abstract
Highly potent, but poorly water-soluble, drug candidates are common outcomes of contemporary drug discovery programmes and present a number of challenges to drug development - most notably, the issue of reduced systemic exposure after oral administration. However, it is increasingly apparent that formulations containing natural and/or synthetic lipids present a viable means for enhancing the oral bioavailability of some poorly water-soluble, highly lipophilic drugs. This Review details the mechanisms by which lipids and lipidic excipients affect the oral absorption of lipophilic drugs and provides a perspective on the possible future applications of lipid-based delivery systems. Particular emphasis has been placed on the capacity of lipids to enhance drug solubilization in the intestinal milieu, recruit intestinal lymphatic drug transport (and thereby reduce first-pass drug metabolism) and alter enterocyte-based drug transport and disposition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conventional absorption and bioavailability assessments, and the body-weight regressions built upon them, implicitly assume the portal route and seldom quantify the lymphatic contribution, even though, for suitable compounds, it can represent a substantial fraction of systemic exposure [29,30].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
In the citing paper
“This route becomes quantitatively relevant only for compounds that combine high lipophilicity with appreciable long-chain triglyceride solubility, for which a log P greater than 5 and a lipid solubility above approximately 50 mg/g are commonly cited as approximate thresholds [29,30].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
In the citing paper
“Because lymphatic delivery reaches the systemic circulation while bypassing hepatic first-pass metabolism, it can materially increase the oral bioavailability of affected compounds and lower their apparent first-pass loss in a manner that a body-weight regression of systemic clearance or volume cannot anticipate [28,29,30].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
In the citing paper
“For highly lipophilic drugs, a fraction of the absorbed dose can bypass the portal circulation entirely and reach the systemic circulation via the intestinal lymphatics, associated with triglyceride-rich lipoproteins (chylomicrons) assembled within the enterocyte [28,29].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
In the citing paper
“The extent of transport is highly sensitive to prandial state and to the type and quantity of co-administered lipid, which differ across preclinical study designs and between the fasted conditions typical of first-in-human protocols and the fed conditions under which lymphatic transport is greatest [29,30].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [29]
Citations
Cites
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734 · cited 1×
“This is especially the case when potent, but highly lipophilic, drug candidates arise from complex chemical scaffolds and multiple high-throughput activity screen”
BackgroundNuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
Apolipoprotein E: Far More Than a Lipid Transport Protein
Mahley, R. W., & Rall, S. C. (2000) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.1.1.507 · Cited by 1,836
Berge, K. E., Tian, H., Graf, G. A., Yu, L., Grishin, N. V., Schultz, J., Kwiterovich, P., Shan, B., Barnes, R., & Hobbs, H. H. (2000) · Science · doi:10.1126/science.290.5497.1771 · Cited by 1,648
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
Altmann, S. W., Davis, H. R., Zhu, L.-J., Yao, X., Hoos, L. M., Tetzloff, G., Iyer, S. P. N., Maguire, M., Golovko, A., Zeng, M., et al. (2004) · Science · doi:10.1126/science.1093131 · Cited by 1,577
Smit, J. J. M., Schinkel, A. H., Elferink, R. P. J. O., Groen, A. K., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., Ottenhoff, R., van der Lugt, N. M. T., van Roon, M. A., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90380-9 · Cited by 1,456
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401 · cited 1×
“In addition to the potential effect of lipidic excipients (primarily surfactants) on P-gp-mediated efflux, Benet and co-workers have recently suggested that high-fat meals could inhibit P-g”
BackgroundSelf-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
Neslihan Gursoy, R., & Benita, S. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.02.001 · Cited by 1,358
Regulation of Absorption and ABC1-Mediated Efflux of Cholesterol by RXR Heterodimers
Repa, J. J., Turley, S. D., Lobaccaro, J.-M. A., Medina, J., Li, L., Lustig, K., Shan, B., Heyman, R. A., Dietschy, J. M., & Mangelsdorf, D. J. (2000) · Science · doi:10.1126/science.289.5484.1524 · Cited by 1,301
Pouton, C. W. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00167-6 · Cited by 1,230 · cited 1×
“Second, several studies have suggested that highly dispersed formulations — and in particular those that self emulsify on contact with GI fluids to provide submicron sized particles ('self-microemulsifying' formulations) — provide for enhanced bioavailability (reviewed in Ref”
BackgroundStudies of Intestinal Digestion and Absorption in the Human1
Borgström, B., Dahlqvist, A., Lundh, G., & Sjövall, J. (1957) · Journal of Clinical Investigation · doi:10.1172/jci103549 · Cited by 1,048
Oliver, W. R., Shenk, J. L., Snaith, M. R., Russell, C. S., Plunket, K. D., Bodkin, N. L., Lewis, M. C., Winegar, D. A., Sznaidman, M. L., Lambert, M. H., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091021198 · Cited by 1,046
VIP21/caveolin is a cholesterol-binding protein.
Murata, M., Peränen, J., Schreiner, R., Wieland, F., Kurzchalia, T. V., & Simons, K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10339 · Cited by 899
Sarkadi, B., Homolya, L., Szakács, G., & Váradi, A. (2006) · Physiological Reviews · doi:10.1152/physrev.00037.2005 · Cited by 726 · cited 1×
“Transporters that have been more frequently implicated in the intestinal efflux of drugs and lipid molecules include the multidrug resistance (MDR) transporter family, multidrug resistance-associated protein (MRP) transporter family and breast cancer resistance protein (BCRP from the ABCG2 gene”
BackgroundOckner, R. K., Manning, J. A., Poppenhausen, R. B., & Ho, W. K. L. (1972) · Science · doi:10.1126/science.177.4043.56 · Cited by 721 · cited 1×
“In particular, FABPs in the small intestine are upregulated at the transcriptional level by chronic exposure to increased quantities of dietary lipid”
BackgroundNuclear Receptors and the Control of Metabolism
Francis, G. A., Fayard, E., Picard, F., & Auwerx, J. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142528 · Cited by 636
Peters, J. M., Lee, S. S. T., Li, W., Ward, J. M., Gavrilova, O., Everett, C., Reitman, M. L., Hudson, L. D., & Gonzalez, F. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5119-5128.2000 · Cited by 633
LXRS AND FXR: The Yin and Yang of Cholesterol and Fat Metabolism
Kalaany, N. Y., & Mangelsdorf, D. J. (2006) · Annual Review of Physiology · doi:10.1146/annurev.physiol.68.033104.152158 · Cited by 615
Davis, H. R., Zhu, L.-J., Hoos, L. M., Tetzloff, G., Maguire, M., Liu, J., Yao, X., Iyer, S. P. N., Lam, M.-H., Lund, E. G., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405817200 · Cited by 615
Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly
Hussain, M. M., Shi, J., & Dreizen, P. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r200014-jlr200 · Cited by 591 · cited 1×
“Triglyceride synthesized by the monoglyceride pathway crosses the SER membran”
BackgroundChan, L. M. S., Lowes, S., & Hirst, B. H. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.07.003 · Cited by 582 · cited 1×
“These transporters most commonly belong to the ATP-binding cassette (ABC) superfamily of proteins, which, as a wider group, comprise membrane transporters, ion channels and receptor”
BackgroundRole of apoCs in lipoprotein metabolism: functional differences between apoC1, apoC2, and apoC3
Jong, M. C., Hofker, M. H., & Havekes, L. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.472 · Cited by 539
The fatty acid transport function of fatty acid-binding proteins
Storch, J., & Thumser, A. E. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00046-9 · Cited by 528 · cited 1×
“It has been suggested that lipid-binding proteins might facilitate the diffusion of lipids across enterocyte”
BackgroundMotojima, K., Passilly, P., Peters, J. M., Gonzalez, F. J., & Latruffe, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16710 · Cited by 524 · cited 1×
“The levels of expression of apical membrane lipid transporter”
BackgroundEffects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers
Rege, B. D., Kao, J. P. Y., & Polli, J. E. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00055-6 · Cited by 509
Willson, T. M., & Kliewer, S. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd753 · Cited by 503 · cited 1×
“NHRs have generated considerable interest recently in the pharmaceutical sciences with the realization of their role in the regulation of detoxification systems, such as cytochrome P450 metabolic enzymes and P-g”
BackgroundHernell, O., Staggers, J. E., & Carey, M. C. (1990) · Biochemistry · doi:10.1021/bi00460a012 · Cited by 490
Carriere, F., Barrowman, J. A., Verger, R., & René, L. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90908-u · Cited by 476
Peroxisome Proliferator-Activated Receptors: From Genes to Physiology
Kliewer, S. A. (2001) · Recent Progress in Hormone Research · doi:10.1210/rp.56.1.239 · Cited by 425
Identification of the Major Intestinal Fatty Acid Transport Protein
Stahl, A., Hirsch, D. J., Gimeno, R. E., Punreddy, S., Ge, P., Watson, N., Patel, S., Kotler, M., Raimondi, A., Tartaglia, L. A., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80332-9 · Cited by 424
Characterization of Fluids from the Stomach and Proximal Jejunum in Men and Women
Lindahl, A., Ungell, A.-L., Knutson, L., & Lennernäs, H. (1997) · Pharmaceutical Research · doi:10.1023/a:1012107801889 · Cited by 408
In vitro assessment of oral lipid based formulations
Porter, C. J. H., & Charman, W. N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00182-x · Cited by 389 · cited 1×
“Exogenous and endogenous solubilizing species Under fasted conditions, the solubilizing species present in the intestinal contents comprise low concentrations of bile salt, phospholipid and cholesterol derived from fasted biliary outpu”
BackgroundSelf-citationWatching Fat Digestion: The formation of visible product phases by pancreatic lipase is described.
Patton, J. S., & Carey, M. C. (1979) · Science · doi:10.1126/science.432636 · Cited by 384
Intestinal Lymph as Pathway for Transport of Absorbed Fatty Acids of Different Chain Lengths
Bloom, B., Chaikoff, I. L., & Reinhardt, W. O. (1951) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1951.166.2.451 · Cited by 374
Lipid-based formulations for intestinal lymphatic delivery
O’Driscoll, C. M. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00051-9 · Cited by 372 · cited 1×
“The potential utility of lipids to enhance bioavailability and lymphatic transport can be assessed by considering lipid-chain length, lipid class, degree of saturation and degree of dispersion; these aspects have been reviewed previousl”
BackgroundThe LXRs: a new class of oxysterol receptors
Peet, D. J., Janowski, B. A., & Mangelsdorf, D. J. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80013-0 · Cited by 364
Biosynthesis of triacylglycerols
Lehner, R., & Kuksis, A. (1996) · Progress in Lipid Research · doi:10.1016/0163-7827(96)00005-7 · Cited by 348 · cited 1×
“Exogenous monoglyceride and fatty acid are primarily re-synthesized to triglyceride by the monoglyceride pathway, which consists of a group of enzymes (triglyceride synthetase) present on the surface of the smooth ER (SER”
BackgroundWestergaard, H., & Dietschy, J. M. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108465 · Cited by 342
Intestinal lymphatic drug transport: an update
Porter, C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00151-x · Cited by 337
Self-citationHauss, D. J., Fogal, S. E., Ficorilli, J. V., Price, C. A., Roy, T., Jayaraj, A. A., & Keirns, J. J. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970300n · Cited by 316
Apolipoprotein B: mRNA Editing, Lipoprotein Assembly, and Presecretory Degradation
Davidson, N. O., & Shelness, G. S. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.169 · Cited by 311
A proposed model for the assembly of chylomicrons
Mahmood Hussain, M. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00397-4 · Cited by 310
Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo
Cornaire, G., Woodley, J., Hermann, P., Cloarec, A., Arellano, C., & Houin, G. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.03.001 · Cited by 307 · cited 1×
“, few studies have managed to conclusively assign an enhancement of drug absorption in vivo to a formulation-related effect on the functionality of P-g”
BackgroundThe Cellular Fatty Acid Binding Proteins: Aspects of Structure, Regulation, and Function
Bass, N. M. (1988) · International Review of Cytology · doi:10.1016/s0074-7696(08)61733-7 · Cited by 305
Orphan nuclear receptors—new ligands and new possibilities: Figure 1.
Blumberg, B., & Evans, R. M. (1998) · Genes & Development · doi:10.1101/gad.12.20.3149 · Cited by 301
ABC transporters in lipid transport
Borst, P., Zelcer, N., & van Helvoort, A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00053-6 · Cited by 300 · cited 1×
“P-gp and other ABC transporters have also been implicated in plasma membrane lipid transport and/or intestinal lipoprotein formatio”
BackgroundCaliph, S. M., Charman, W. N., & Porter, C. J. H. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200008)89:8<1073::aid-jps12>3.0.co;2-v · Cited by 292 · cited 1×
“An additional feature to consider when comparing in vitro solubilization and in vivo bioavailability data, and in particular the impact of medium-chain or long-chain lipids, are the differential effects of these lipids on intestinal lymphatic transpor”
BackgroundSelf-citationStaggers, J. E., Hernell, O., Stafford, R. J., & Carey, M. C. (1990) · Biochemistry · doi:10.1021/bi00460a011 · Cited by 289
Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism
Shachter, N. S. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200106000-00009 · Cited by 288
CAR and PXR: Xenosensors of endocrine disrupters?
Kretschmer, X. C., & Baldwin, W. S. (2005) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.06.003 · Cited by 268
The Peroxisome Proliferator-activated Receptor δ Promotes Lipid Accumulation in Human Macrophages
Vosper, H., Patel, L., Graham, T. L., Khoudoli, G. A., Hill, A., Macphee, C. H., Pinto, I., Smith, S. A., Suckling, K. E., Wolf, C. R., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108482200 · Cited by 268
Persson, E. M., Gustafsson, A.-S., Carlsson, A. S., Nilsson, R. G., Knutson, L., Forsell, P., Hanisch, G., Lennernäs, H., & Abrahamsson, B. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8192-x · Cited by 266 · cited 1×
“Exogenous and endogenous solubilizing species Under fasted conditions, the solubilizing species present in the intestinal contents comprise low concentrations of bile salt, phospholipid and cholesterol derived from fasted biliary outpu”
BackgroundCD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood
Drover, V. A., Ajmal, M., Nassir, F., Davidson, N. O., Nauli, A. M., Sahoo, D., Tso, P., & Abumrad, N. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200521514 · Cited by 265
Mechanisms of digestion and absorption of dietary vitamin A
Harrison, E. H. (2005) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.25.050304.092614 · Cited by 262
Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum
Armand, M., Borel, P., Pasquier, B., Dubois, C., Senft, M., Andre, M., Peyrot, J., Salducci, J., & Lairon, D. (1996) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1996.271.1.g172 · Cited by 259
Guadalupe, M., Sankaran, S., George, M. D., Reay, E., Verhoeven, D., Shacklett, B. L., Flamm, J., Wegelin, J., Prindiville, T., & Dandekar, S. (2006) · Journal of Virology · doi:10.1128/jvi.00120-06 · Cited by 251 · cited 1×
“— with recent evidence suggesting that HIV replication occurs largely in gut-associated lymphoid tissu”
BackgroundBell, R. M., Ballas, L. M., & Coleman, R. A. (1981) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34952-x · Cited by 251
Identification of a Receptor Mediating Absorption of Dietary Cholesterol in the Intestine
Hauser, H., Dyer, J. H., Nandy, A., Vega, M. A., Werder, M., Bieliauskaite, E., Weber, F. E., Compassi, S., Gemperli, A., Boffelli, D., et al. (1998) · Biochemistry · doi:10.1021/bi982404y · Cited by 250 · cited 1×
“A number of transport proteins have also been implicated in cholesterol uptake across the enterocyte plasma membrane, including scavenger receptor B”
BackgroundIntestinal lipid absorption and transport
Phan, C. (2001) · Frontiers in Bioscience · doi:10.2741/phan · Cited by 247
Porter, C. J. H., Kaukonen, A. M., Boyd, B. J., Edwards, G. A., & Charman, W. N. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000036914.22132.cc · Cited by 242 · cited 1×
“and studies have shown similar drug absorption patterns after administration of 2–10 g of formulated lipid when compared with post-prandial administratio”
BackgroundSelf-citationHugger, E. D., Novak, B. L., Burton, P. S., Audus, K. L., & Borchardt, R. T. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10176 · Cited by 237
Lo, Y.-L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00163-9 · Cited by 233
Formation and transport of chylomicrons by enterocytes to the lymphatics
Tso, P., & Balint, J. A. (1986) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1986.250.6.g715 · Cited by 231
Uptake of fatty acids by jejunal mucosal cells is mediated by a fatty acid binding membrane protein.
Stremmel, W. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113820 · Cited by 220 · cited 1×
“The products of lipid digestion are absorbed across the apical membrane into the enterocyte by activ”
BackgroundEstimating the Maximal Potential for Intestinal Lymphatic Transport of Lipophilic Drug Molecules
Charman, W. N. A., & Stella, V. J. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90027-x · Cited by 217
Self-citationPorter, C. J. H., Kaukonen, A. M., Taillardat-Bertschinger, A., Boyd, B. J., O'Connor, J. M., Edwards, G. A., & Charman, W. N. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20039 · Cited by 216
Self-citationOrphan Nuclear Receptors: The Exotics of Xenobiotics
Xie, W., & Evans, R. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100033200 · Cited by 210
Poirier, H., Degrace, P., Niot, I., Bernard, A., & Besnard, P. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0368z.x · Cited by 209 · cited 1×
“A number of potential apical membrane fatty-acid transporters have been identified, including CD36 and the fatty-acid transporter (FAT”
BackgroundConstantinides, P. P., & Wasan, K. M. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20780 · Cited by 207
Batrakova, E. V., Li, S., Miller, D. W., & Kabanov, A. V. (1999) · Pharmaceutical Research · doi:10.1023/a:1018990706838 · Cited by 206
Kaukonen, A. M., Boyd, B. J., Porter, C. J. H., & Charman, W. N. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016282.77887.1f · Cited by 206
Self-citationCaco‐2 cells as a model for intestinal lipoprotein synthesis and secretion
Levy, E., Mehran, M., & Seidman, E. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.8.7768354 · Cited by 205 · cited 1×
“In the drug development field, Caco-2 cells are well known as a high-throughput screen for the assessment of intestinal drug permeability, but this cell line is also used in lipid biochemistry to examine aspects of intracellular lipoprotein assembl”
BackgroundNauli, A. M., Nassir, F., Zheng, S., Yang, Q., Lo, C., VonLehmden, S. B., Lee, D., Jandacek, R. J., Abumrad, N. A., & Tso, P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.08.012 · Cited by 204
Organic anion‐transporting polypeptide (OATP) transporter family and drug disposition
Kim, R. B. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.33.s2.5.x · Cited by 200
Kossena, G. A., Boyd, B. J., Porter, C. J. H., & Charman, W. N. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10329 · Cited by 199 · cited 1×
“In the presence of phospholipid, bile salt concentrations remain above the critical micelle concentration ; however, the nature and size of the colloidal structures present are dependent on the proportions of each of the included component”
BackgroundSelf-citationDifferences in the Intestinal Absorption of Saturated and Unsaturated Long Chain Fatty Acids
Ockner, R. K., Pittman, J. P., & Yager, J. L. (1972) · Gastroenterology · doi:10.1016/s0016-5085(72)80115-x · Cited by 198
Charman, W. N., & Stella, V. J. (2019) · Routledge eBooks · doi:10.1201/9780203748572 · Cited by 195
Self-citationDahan, A., & Hoffman, A. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9054-x · Cited by 195
Tissue Distribution of Human gp330/Megalin, a Putative Ca2+-sensing Protein
Lundgren, S., Carling, T., Hjälm, G., Juhlin, C., Rastad, J., Pihlgren, U., Rask, L., Åkerström, G., & Hellman, P. (1997) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549704500306 · Cited by 195
Johnson, B. M., Charman, W. N., & Porter, C. J. H. (2002) · AAPS PharmSci · doi:10.1208/ps040440 · Cited by 193
Self-citationChristensen, J. Ø., Schultz, K., Mollgaard, B., Kristensen, H. G., & Mullertz, A. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.08.003 · Cited by 186
Gastrointestinal adaptation to diets of differing fat composition in human volunteers.
Cunningham, K. M., Daly, J., Horowitz, M., & Read, N. W. (1991) · Gut · doi:10.1136/gut.32.5.483 · Cited by 185 · cited 1×
“The specific mechanisms by which lipids reduce gastric emptying are not clear and competing factors such as osmolality, calorific volume and pH are also likely to mediate changes to the gastric-emptying pattern”
BackgroundBogman, K., Erne-Brand, F., Alsenz, J., & Drewe, J. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10395 · Cited by 184
Collnot, E.-M., Baldes, C., Wempe, M. F., Hyatt, J., Navarro, L., Edgar, K. J., Schaefer, U. F., & Lehr, C.-M. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.11.005 · Cited by 184
Intestinal lipid absorption and transport
Phan, C. T. (2001) · Frontiers in bioscience · doi:10.2741/a612 · Cited by 184
Hamosh, M., Scanlon, J. W., Ganot, D., Likel, M., Scanlon, K. B., & Hamosh, P. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110101 · Cited by 181
Dahan, A., & Hoffman, A. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.12.006 · Cited by 179 · cited 1×
“Recently, a less invasive in vivo approach to the estimation of intestinal lymphatic drug transport has been described in which the systemic exposure of the drug is assessed after administration in the presence and absence of Pluronic-L81 or colchicine”
BackgroundRole of Lymphoid Organs in the Pathogenesis of Human Immunodeficiency Virus (HIV) Infection
Pantaleo, G., Graziosi, C., Demarest, J. F., Cohen, O. J., Vaccarezza, M., Gantt, K., Muro‐Cacho, C., & Fauci, A. S. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00867.x · Cited by 178 · cited 1×
“The lymphatic system also has an important role in the dissemination of tumour metastases and acts as a reservoir for the human immunodeficiency virus (HIV”
BackgroundApical Sodium Dependent Bile Acid Transporter (ASBT, SLC10A2): A Potential Prodrug Target
Balakrishnan, A., & Polli, J. E. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060022d · Cited by 178
Mueller, E. A., Kovarik, J. M., van Bree, J. B., Grevel, J., Lücker, P. W., & Kutz, K. (1994) · Pharmaceutical Research · doi:10.1023/a:1018922517162 · Cited by 170 · cited 1×
“and studies have shown similar drug absorption patterns after administration of 2–10 g of formulated lipid when compared with post-prandial administratio”
BackgroundEhehalt, R., Füllekrug, J., Pohl, J., Ring, A., Herrmann, T. R. W., & Stremmel, W. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-9034-1 · Cited by 167
THE PORTAL TRANSPORT OF ABSORBED FATTY ACIDS
Kiyasu, J. Y., Bloom, B., & Chaikoff, I. L. (1952) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)44850-8 · Cited by 165
Shono, Y., Nishihara, H., Matsuda, Y., Furukawa, S., Okada, N., Fujita, T., & Yamamoto, A. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20017 · Cited by 165
Feinle, C., Rades, T., Otto, B., & Fried, M. (2001) · Gastroenterology · doi:10.1053/gast.2001.23232 · Cited by 164 · cited 1×
“The specific mechanisms by which lipids reduce gastric emptying are not clear and competing factors such as osmolality, calorific volume and pH are also likely to mediate changes to the gastric-emptying pattern”
BackgroundEffect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers
Ingels, F., Beck, B., Oth, M., & Augustijns, P. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.01.014 · Cited by 162 · cited 1×
“Interestingly, high-fat meals also stimulate the release of biliary lipids and these studies are therefore consistent with others that suggest that intestinal fluids, which contain bile salt and phospholipid, inhibit P-gp-mediated drug efflu”
ResultKalantzi, L., Persson, E., Polentarutti, B., Abrahamsson, B., Goumas, K., Dressman, J. B., & Reppas, C. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0207-8 · Cited by 159
Cuiné, J. F., Charman, W. N., Pouton, C. W., Edwards, G. A., & Porter, C. J. H. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9194-z · Cited by 157 · cited 1×
“, and that digestion of certain surfactants might lead to significant decreases in solubilization capacity for some formulation”
BackgroundSelf-citationWillems van Dijk, K., Rensen, P. C., Voshol, P. J., & Havekes, L. M. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200406000-00002 · Cited by 154
Seedorf, U., Ellinghaus, P., & Nofer, J. R. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00047-0 · Cited by 151
Khoo, S., Shackleford, D. M., Porter, C. J. H., Edwards, G. A., & Charman, W. N. (2003) · Pharmaceutical Research · doi:10.1023/a:1025718513246 · Cited by 150 · cited 1×
“However, a recent study in fasted dogs has shown that administration of a single capsule of long-chain lipid can stimulate significant lymphatic transport of halofantrine (27% of the dose) after oral administratio”
BackgroundSelf-citationMechanism of pancreatic lipase action. 1. Interfacial activation of pancreatic lipase
Chapus, C., Sémériva, M., Bovier-Lapierre, C., & Desnuelle, P. (1976) · Biochemistry · doi:10.1021/bi00668a006 · Cited by 150 · cited 1×
“Lipids are crudely emulsified in the stomach, and subsequently enter the small intestine where quantitative digestion of triglyceride is completed by pancreatic lipase at the oil–water interfac”
BackgroundDirect measurement by pH-microelectrode of the pH microclimate in rat proximal jejunum
Lucas, M. L., Schneider, W., Haberich, F. J., & Blair, J. A. (1975) · Proceedings of the Royal Society of London. Series B. Biological Sciences · doi:10.1098/rspb.1975.0150 · Cited by 149
POIRIER, H., NIOT, I., MONNOT, M.-C., BRAISSANT, O., MEUNIER-DURMORT, C., COSTET, P., PINEAU, T., WAHLI, W., WILLSON, T. M., & BESNARD, P. (2001) · Biochemical Journal · doi:10.1042/bj3550481 · Cited by 149
Lipid absorptions passing through the unstirred layers, brush-border membrane, and beyond
Thomson, A. B. R., Schoeller, C., Keelan, M., Smith, L., & Clandinin, M. T. (1993) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y93-078 · Cited by 148
On the mechanism of pancreatic lipolysis of glycerides
Borgström, B. (1954) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(54)90365-0 · Cited by 144
Effect of Food and a Monoglyceride Emulsion Formulation on Danazol Bioavailability
Charman, W. N., Rogge, M. C., Boddy, A. W., & Berger, B. M. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb04673.x · Cited by 142
Self-citationIntestinal aspects of lipid absorption: in review
Thomson, A. B. R., Keelan, M., Garg, M. L., & Clandinin, M. T. (1989) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y89-031 · Cited by 142
A Comparison of the Solubility of Danazol in Human and Simulated Gastrointestinal Fluids
Pedersen, B. L., Müllertz, A., BRØNDSTED, H. V., & Kristensen, H. G. (2000) · Pharmaceutical Research · doi:10.1023/a:1007576713216 · Cited by 141
The ileal brake: A fifteen-year progress report
Citters, G. W. V., & Lin, H. C. (1999) · Current Gastroenterology Reports · doi:10.1007/s11894-999-0022-6 · Cited by 137
Accelerated Lipid Absorption in Mice Overexpressing Intestinal SR-BI
Bietrix, F., Yan, D., Nauze, M., Rolland, C., Bertrand-Michel, J., Coméra, C., Schaak, S., Barbaras, R., Groen, A. K., Perret, B., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508868200 · Cited by 134
Kossena, G. A., Charman, W. N., Boyd, B. J., Dunstan, D. E., & Porter, C. J. H. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10554 · Cited by 133
Self-citationIntestinal Drug Transporters: In Vivo Function and Clinical Importance
Kunta, J., & Sinko, P. (2004) · Current Drug Metabolism · doi:10.2174/1389200043489144 · Cited by 133 · cited 1×
“in the transport of drugs, which resemble their endogenous ligand”
BackgroundGershkovich, P., & Hoffman, A. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.07.011 · Cited by 132 · cited 1×
“Lipids and changes to enterocyte biology The potential for lipids and lipidic excipients to interact with lipid and drug transport pathways into and across the enterocyte has emerged as a growing area of interes”
BackgroundTransport of Peptidomimetic Drugs by the Intestinal Di/tri‐peptide Transporter, PepT1
Brodin, B., Nielsen, C. U., Steffansen, B., & Frøkjær, S. (2002) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2002.900601.x · Cited by 131
Fat feeding increases size, but not number, of chylomicrons produced by small intestine
Hayashi, H., Fujimoto, K., Cardelli, J. A., Nutting, D. F., Bergstedt, S., & Tso, P. (1990) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1990.259.5.g709 · Cited by 129
Porter, C. J. H., Charman, S. A., & Charmanx, W. N. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950221g · Cited by 129 · cited 1×
“Lipid-based formulations with physical characteristics that are representative of the final stages of lipid digestion (for example, mixed micellar systems that contain lipid digestion products such as fatty acids and monoglycerides) rather than crude emulsions or lipid solutions have been shown to promote the lymphati…”
BackgroundSelf-citationIntestinal lipoprotein assembly
Hussain, M. M., Fatma, S., Pan, X., & Iqbal, J. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000169347.53568.5a · Cited by 128
Pancreatic colipase. Structural and physiological aspects
Erlanson‐Albertsson, C. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90147-n · Cited by 128
Strauss, E. W. (1966) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39296-8 · Cited by 128
P-glycoprotein and surfactants: Effect on intestinal talinolol absorption
BOGMAN, K., ZYSSET, Y., DEGEN, L., HOPFGARTNER, G., GUTMANN, H., ALSENZ, J., & DREWE, J. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.09.001 · Cited by 126 · cited 1×
“One exception is a recent study that described an inhibitory effect of tocopheryl polyethylene glycol 1,000 succinate (TPGS) on the efflux of talinolol by P-gp in vitro and subsequently showed an enhancement in the oral bioavailability of talinolol in human”
BackgroundLipophilic prodrugs designed for intestinal lymphatic transport
Charman, W. N., & Porter, C. J. H. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00105-g · Cited by 124 · cited 1×
“Lipidic prodrugs comprise drugs that are covalently bound to a lipid moiety such as a fatty acid, diglyceride or phosphoglyceride, which is subsequently cleaved following uptake into the systemic circulation to liberate the parent dru”
BackgroundSelf-citationNew insights into the fatty acid-binding protein (FABP) family in the small intestine
Besnard, P., Niot, I., Poirier, H., Clément, L. C., & Bernard, A. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1020505512364 · Cited by 120 · cited 1×
“Cytosolic lipid-binding proteins in the small intestine include intestine and liver fatty-acid-binding protein (L-FABP”
BackgroundYang, L., & Kuksis, A. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41980-7 · Cited by 120
Peeters, T. L., Vantrappen, G. R., & Janssens, J. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90244-9 · Cited by 119
An examination of the factors affecting intestinal lymphatic transport of dietary lipids
Nordskog, B. K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00147-8 · Cited by 116 · cited 1×
“A further barrier to the effective uptake of lipids from the intestinal lumen into enterocytes is diffusion across the unstirred water layer, which separates the bulk fluid phase of the small intestine lumen from the brush border membrane of enterocyte”
BackgroundLong-Chain Fatty Acid Uptake into Adipocytes Depends on Lipid Raft Function
Pohl, J., Ring, A., Ehehalt, R., Schulze-Bergkamen, H., Schad, A., Verkade, P., & Stremmel, W. (2004) · Biochemistry · doi:10.1021/bi035743m · Cited by 114
Uptake of long-chain fatty acids in HepG2 cells involves caveolae
Pohl, J., Ring, A., & Stremmel, W. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m100404-jlr200 · Cited by 114
Shackleford, D. M., Faassen, W. A., Houwing, N. S., Lass, H., Edwards, G. A., Porter, C. J. H., & Charman, W. N. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052522 · Cited by 113
Self-citationAnimal models for the study of intestinal lymphatic drug transport
Edwards, G. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00148-x · Cited by 112 · cited 1×
“Consequently, various animal models have been developed to estimate the likely intestinal lymphatic drug transport in human”
BackgroundKhoo, S., Edwards, G. A., Porter, C. J. H., & Charman, W. N. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1110 · Cited by 111
Self-citationZastre, J. A., Jackson, J. K., Bajwa, M. S., Liggins, R., Iqbal, F., & Burt, H. M. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00119-4 · Cited by 109
Chiu, Y.-Y., Higaki, K., Neudeck, B. L., Barnett, J. L., Welage, L. S., & Amidon, G. L. (2003) · Pharmaceutical Research · doi:10.1023/a:1023481418576 · Cited by 106
Intracellular lipid binding proteins of the small intestine
Agellon, L. B., Toth, M. J., & Thomson, A. B. R. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1020520521025 · Cited by 104 · cited 1×
“After absorption across the apical membrane, lipid digestion products can cross the enterocyte by diffusion around the apical and basolateral membranes or can diffuse across the cytosol either alone or through association with intracellular lipid-binding proteins (iLBPs”
BackgroundKossena, G. A., Charman, W. N., Boyd, B. J., & Porter, C. J. H. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20260 · Cited by 104 · cited 1×
“However the solubilization capacity is dependent on lipid concentration, and the solubility of a range of poorly water-soluble drugs has been shown to be enhanced by less than threefold at lower (”
BackgroundSelf-citationIntestinal lipoprotein synthesis and secretion
Field, F. J., & Mathur, S. N. (1995) · Progress in Lipid Research · doi:10.1016/0163-7827(95)00005-k · Cited by 103 · cited 1×
“P-gp and other ABC transporters have also been implicated in plasma membrane lipid transport and/or intestinal lipoprotein formatio”
BackgroundSapecin B, a novel fly toxin, blocks macroscopic K+ currents in the GH3 rat pituitary cell line
Suzuki, N., Hirono, M., Kawahara, K., & Yoshioka, T. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.273.1.c289 · Cited by 102
Evolution and mechanism of apolipoprotein B-containing lipoprotein assembly
Shelness, G. S., & Ledford, A. S. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000169353.12772.eb · Cited by 100
Brouwers, J., Tack, J. F., Lammert, F., & Augustijns, P. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20553 · Cited by 99 · cited 1×
“Exogenous and endogenous solubilizing species Under fasted conditions, the solubilizing species present in the intestinal contents comprise low concentrations of bile salt, phospholipid and cholesterol derived from fasted biliary outpu”
BackgroundThe effect of different oils on the absorption of probucol in the rat
Palin, K. J., & Wilson, C. G. (1984) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1984.tb04919.x · Cited by 99
Common mechanisms of monoacylglycerol and fatty acid uptake by human intestinal Caco-2 cells
Ho, S.-Y., & Storch, J. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.281.4.c1106 · Cited by 95
Apolipoprotein A-IV, food intake, and obesity
Tso, P., & Liu, M. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.07.032 · Cited by 94
On the positional specificity of phospholipase A from pancreas
van den BOSCH, H., Postema, N. M., Haas, G. H. D., & Deenen, L. L. M. V. (1965) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(65)90168-2 · Cited by 91
Inhibition of gastric emptying in response to intestinal lipid is dependent on chylomicron formation
Raybould, H. E., Meyer, J. H., Tabrizi, Y., Liddle, R. A., & Tso, P. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.6.r1834 · Cited by 90
Myers, R. A., & Stella, V. J. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90374-b · Cited by 89 · cited 1×
“There are also reports of enhanced oral bioavailability after administration in medium-chain rather than long-chain lipid-based vehicles for drugs such as progesterone and penclomedin”
BackgroundTso, P., Drake, D. S., Black, D. D., & Sabesin, S. M. (1984) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1984.247.6.g599 · Cited by 89
Gastric Lipase: Localization in the Human Stomach
Abrams, C. K., Hamosh, M., Lee, T. C., Ansher, A. F., Collen, M. J., Lewis, J. H., Benjamin, S. B., & Hamosh, P. (1988) · Gastroenterology · doi:10.1016/s0016-5085(88)80063-5 · Cited by 86
In Vitro Model for Ciclosporin Intestinal Absorption in Lipid Vehicles
Reymond, J.-P., & Sucker, H. (1988) · Pharmaceutical Research · doi:10.1023/a:1015987223407 · Cited by 85
Purification and properties of triglyceride synthetase from the intestinal mucosa
Rao, G. A., & Johnston, J. M. (1966) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(66)90035-x · Cited by 85 · cited 1×
“Exogenous monoglyceride and fatty acid are primarily re-synthesized to triglyceride by the monoglyceride pathway, which consists of a group of enzymes (triglyceride synthetase) present on the surface of the smooth ER (SER”
BackgroundMicrosomal triglyceride transfer protein a multifunctional protein
Hussain, M. M. (2003) · Frontiers in Bioscience · doi:10.2741/1071 · Cited by 84 · cited 1×
“Triglyceride synthesized by the monoglyceride pathway crosses the SER membran”
BackgroundUeda, C. T., Lemaire, M., Gsell, G., & Nussbaumer, K. (1983) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510040203 · Cited by 84
Dissolution of Hydrocortisone in Human and Simulated Intestinal Fluids
Pedersen, B. L., BRØNDSTED, H. V., Lennernäs, H., Christensen, F. N., Müllertz, A., & Kristensen, H. G. (2000) · Pharmaceutical Research · doi:10.1023/a:1007517414200 · Cited by 83
Monoacylglycerol Metabolism in Human Intestinal Caco-2 Cells
Ho, S.-Y., Delgado, L., & Storch, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108027200 · Cited by 82 · cited 1×
“Similarly, apical membrane transporters for monoglyceride have been describe”
BackgroundEffects of fasting on bile acid metabolism and biliary lipid composition in man
Duane, W. C., Ginsberg, R. L., & Bennion, L. J. (1976) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36977-7 · Cited by 81
Fatty acid regulation of fatty acid-binding protein expression in the small intestine
Poirier, H., Niot, I., Degrace, P., Monnot, M. C., Bernard, A., & Besnard, P. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.2.g289 · Cited by 80
Sulfhydryls on frog skeletal muscle membrane participate in contraction
Oba, T., & Yamaguchi, M. (1990) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1990.259.5.c709 · Cited by 79
Hool, L. C., Gray, D. F., Robinson, B. G., & Rasmussen, H. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.1.c172 · Cited by 78
Immunocytolocalization of human gastric lipase in chief cells of the fundic mucosa
Moreau, H., Bernadac, A., Gargouri, Y., Benkouka, F., Laugier, R., & Verger, R. (1989) · Histochemistry and Cell Biology · doi:10.1007/bf00493829 · Cited by 77 · cited 1×
“After oral administration, the presence of lipid in the GI tract leads to secretion of gastric lipase from the chief cells lining the gastric mucos”
BackgroundThe Entry of Foreign Compounds into the Thoracic Duct Lymph of the Rat
Steber, S. M., Cohn, V. H., & Wynn, W. T. (1974) · Xenobiotica · doi:10.3109/00498257409052055 · Cited by 77
Analysis of conjugated and unconjugated bile acids in serum and jejunal fluid of normal subjects
Tangerman, A., van Schaik, A., & van der Hoek, E. W. (1986) · Clinica Chimica Acta · doi:10.1016/0009-8981(86)90044-6 · Cited by 76
Effects of lipid class and lipid vehicle volume on the intestinal lymphatic transport of DDT
Charman, W. N., & Stella, V. J. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90050-5 · Cited by 76
Self-citationMurota, K., & Storch, J. (2005) · Journal of Nutrition · doi:10.1093/jn/135.7.1626 · Cited by 76
Mizuma, T., Ohta, K., Hayashi, M., & Awazu, S. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90649-4 · Cited by 75
Seeballuck, F., Lawless, E., Ashford, M. B., & O’Driscoll, C. M. (2004) · Pharmaceutical Research · doi:10.1007/s11095-004-7684-4 · Cited by 75 · cited 1×
“Recently, Caco-2 cells have also been used to examine the influence of lipids and lipid-formulation excipients on drug incorporation into lipoproteins and the initial data are encouragin”
MEUNIER-DURMORT, C., POIRIER, H., NIOT, I., FOREST, C., & BESNARD, P. (1996) · Biochemical Journal · doi:10.1042/bj3190483 · Cited by 74
Seeballuck, F., Ashford, M. B., & O’Driscoll, C. M. (2003) · Pharmaceutical Research · doi:10.1023/a:1024422625596 · Cited by 73 · cited 1×
“Recently, Caco-2 cells have also been used to examine the influence of lipids and lipid-formulation excipients on drug incorporation into lipoproteins and the initial data are encouragin”
A comparison of absorption of glycerol tristearate and glycerol trioleate by rat small intestine
Bergstedt, S. E., Hayashi, H., Kritchevsky, D., & Tso, P. (1990) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1990.259.3.g386 · Cited by 73
Koo, S. I., & Noh, S. K. (2001) · Journal of Nutrition · doi:10.1093/jn/131.3.717 · Cited by 73
A dual, concentration-dependent absorption mechanism of linoleic acid by rat jejunum in vitro.
Chow, S. L., & Hollander, D. (1979) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40617-0 · Cited by 72
Boyd, M. C., Risovic, V., Jull, P., Choo, E., & Wasan, K. M. (2004) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2003.11.004 · Cited by 70 · cited 1×
“Consequently, various animal models have been developed to estimate the likely intestinal lymphatic drug transport in human”
BackgroundSek, L., Boyd, B. J., Charman, W. N., & Porter, C. J. H. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.6.0011 · Cited by 70 · cited 1×
“Indeed recent data from our laboratories suggest that product performance is poorly related to the initial particle size of a dispersed formulation and instead is correlated more with the patterns of solubilization obtained after dispersion and digestion of the formulation in simulated intestinal flui”
ResultSelf-citation“Inactive” excipients such as Cremophor can affect in vivo drug disposition
Wandel, C., Kim, R. B., & Stein, C. M. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00010-9 · Cited by 70
Ladas, S. D., Isaacs, P. E. T., Murphy, G. M., & Sladen, G. E. (1984) · Gut · doi:10.1136/gut.25.4.405 · Cited by 70
Konishi, T., Satsu, H., Hatsugai, Y., Aizawa, K., Inakuma, T., Nagata, S., Sakuda, S., Nagasawa, H., & Shimizu, M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705804 · Cited by 69 · cited 1×
“have shown increased accumulation of a P-gp drug substrate in Caco-2 cells on incubation of the cells with monoglycerid”
BackgroundPersson, E. M., Nilsson, R. G., Hansson, G. I., Löfgren, L., Libäck, F., Knutson, L., Abrahamsson, B., & Lennernäs, H. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9607-z · Cited by 68 · cited 1×
“recently suggested that a post-prandial response is stimulated, at least in part, by as little as 7 g of lipi”
BackgroundIntestinal triglycerides are derived from both endogenous and exogenous sources
Shiau, Y. F., Popper, D. A., Reed, M., Umstetter, C., Capuzzi, D., & Levine, G. M. (1985) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1985.248.2.g164 · Cited by 68
Porter, C. J. H., Charman, S. A., Humberstone, A. J., & Charman, W. N. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js9502229 · Cited by 67
Self-citationHuman ABC Transporter ABCG2 in Xenobiotic Protection and Redox Biology
Wakabayashi, K., Tamura, A., Saito, H., Onishi, Y., & Ishikawa, T. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600727947 · Cited by 66
Hauss, D. J., Mehta, S. C., & Radebaugh, G. W. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90318-2 · Cited by 65
Katneni, K., Charman, S. A., & Porter, C. J. H. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20687 · Cited by 64 · cited 1×
“Also, even in vitro the inevitable reduction in thermodynamic activity that the inclusion of a solubilizing species in a transport buffer effects requires careful data interpretatio”
BackgroundSelf-citationFried, M., Mayer, E. A., Jansen, J. B. �. �., Lamers, C. B. H. W., Taylor, I. L., Bloom, S. R., & Meyer, J. H. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90371-x · Cited by 63
The Interaction of Lipophilic Drugs with Intestinal Fatty Acid-binding Protein
Velkov, T., Chuang, S., Wielens, J., Sakellaris, H., Charman, W. N., Porter, C. J. H., & Scanlon, M. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410193200 · Cited by 61 · cited 1×
“Lipids and changes to enterocyte biology The potential for lipids and lipidic excipients to interact with lipid and drug transport pathways into and across the enterocyte has emerged as a growing area of interes”
BackgroundSelf-citationOh, D.-M., Han, H.-K., & Amidon, G. L. (2002) · Pharmaceutical biotechnology · doi:10.1007/0-306-46812-3_3 · Cited by 60
Role of Biliary Lecithin in Lymphatic Transport of Fat
Tso, P., Balint, J. A., & Simmonds, W. J. (1977) · Gastroenterology · doi:10.1016/s0016-5085(19)31514-8 · Cited by 60
Dulfer, W. J., Groten, J. P., & Govers, H. A. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42006-1 · Cited by 59
Regulation of gene expression by fatty acids: Special reference to fatty acid-binding protein (FABP)
Niot, I., Poirier, H., & Besnard, P. (1997) · Biochimie · doi:10.1016/s0300-9084(97)81504-0 · Cited by 59
Hypertrophy of isolated adult feline heart cells following beta-adrenergic-induced beating
Clark, W. A., Rudnick, S. J., LaPres, J. J., Lesch, M., & Decker, R. S. (1991) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1991.261.3.c530 · Cited by 59
Noguchi, T., Charman, W. N., & Stella, V. J. (1985) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(85)90018-3 · Cited by 57 · cited 1×
“In terms of lipid class (for example, fatty acid, monoglyceride, diglyceride, triglyceride or phospholipid), many studies have examined the effect of administering either fatty acid or triglyceride on the rate and extent of lymphatic drug transpor”
BackgroundSelf-citationThe relationship between uptake in vitro of oleic acid and micellar solubilization
Hoffman, N. (1970) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(70)90006-4 · Cited by 56
Portal transport of absorbed lipids in rats
Mansbach CM, I. I., Dowell, R. F., & Pritchett, D. (1991) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1991.261.3.g530 · Cited by 56
Katneni, K., Charman, S. A., & Porter, C. J. H. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20779 · Cited by 55
Self-citationEffect of Polyoxyl 35 Castor Oil and Polysorbate 80 on the Intestinal Absorption of Digoxin in vitro
Cornaire, G., Woodley, J., Saivin, S., Legendre, J.-Y., Decourt, S., Cloarec, A., & Houin, G. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1300252 · Cited by 53
Dubé, N., DELVIN, E. E., Yotov, W. V., Garofalo, C., Bendayan, M., Veerkamp, J. H., & Levy, E. H. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1090 · Cited by 52
Chylomicron components mediate intestinal lipid-induced inhibition of gastric motor function
Glatzle, J., Kalogeris, T. J., Zittel, T. T., Guerrini, S., Tso, P., & Raybould, H. E. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2002.282.1.g86 · Cited by 52
Regulation of gastric and pancreatic lipase secretion by CCK and cholinergic mechanisms in humans
Borovicka, J., Schwizer, W., Mettraux, C., Kreiss, C. M., Remy, B., Asal, K., Jansen, J. B. �. �., Douchet, I., Verger, R., & Fried, M. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.2.g374 · Cited by 51
Modulation of gastric distension-induced sensations by small intestinal receptors
Feinle, C., Grundy, D., & Fried, M. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.1.g51 · Cited by 51
Duodenal Bile Acids after a Test Meal
Fausa, O. (1974) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.1974.12096876 · Cited by 51
The Lymph Lipid Precursor Pool Is a Key Determinant of Intestinal Lymphatic Drug Transport
Trevaskis, N. L., Porter, C. J. H., & Charman, W. N. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094094 · Cited by 49 · cited 1×
“Other than glycerides, phospholipids and their digestion products have been shown to enhance the lymphatic uptake of halofantrin”
BackgroundSelf-citationFactors influencing triacylglycerol delivery into mesenteric lymph
Mansbach, C. M., Arnold, A., & Cox, M. A. (1985) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1985.249.5.g642 · Cited by 49
Triglyceride Biosynthesis in the Intestinal Mucosa
Johnston, J. M. (1976) · Springer eBooks · doi:10.1007/978-94-011-7176-2_7 · Cited by 48
Cited by
McClements, D. J., & Rao, J. (2011) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.559558 · Cited by 1,630
“Lipid digestion also depends on the molecular characteristics of digestible triacylglycerols oils, eg, medium-chain triglycerides (MCT) tend to be digested more rapidly than long-chain triglycerides (corn oil) ( Porter et al, 2007 ).”
BackgroundStrategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
“Lymphatic drug transport has been described for many highly lipophilic drugs and has been the subject of several reviews (Porter and Charman, 2001b; O’Driscoll, 2002; Porter et al., 2007; Trevaskis et al., 2008; Yanez et al., 2011).”
BackgroundMethodInfluentialSelf-citationNanoemulsion: Concepts, development and applications in drug delivery
Singh, Y., Meher, J. G., Raval, K., Khan, F. A., Chaurasia, M., Jain, N. K., & Chourasia, M. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.008 · Cited by 1,358
“Drugs which enter mesenteric lymph are directly transported to systemic circulation without undergoing hepatic first pass metabolism[92].”
BackgroundBiomedical Applications of Supramolecular Systems Based on Host–Guest Interactions
Ma, X., & Zhao, Y. (2015) · Chemical Reviews · doi:10.1021/cr500392w · Cited by 1,225
McClements, D. J., & Li, Y. (2010) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2010.06.010 · Cited by 905
Metadata
- Authors
- Porter, C. J. H., Trevaskis, N. L., & Charman, W. N.
- Affiliations
- Monash University (AU)
- Corresponding author
- Porter, Christopher J. H.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-03
- Volume
- 6
- Issue
- 3
- Pages
- 231-248
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2069235788
- Cited by
- 1,824
- References
- 253
- Citations by year
- 2026: 88 · 2025: 87 · 2024: 67 · 2023: 89 · 2022: 119 · 2021: 108 · 2020: 140 · 2019: 101 · 2018: 117 · 2017: 121 · 2016: 125 · 2015: 119 · 2014: 120 · 2013: 128 · 2012: 94
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- lipid-based drug delivery, oral bioavailability, lipophilic drugs, poorly water-soluble drugs, lipid excipients, first-pass metabolism, lipid-based formulations
- MeSH terms
- Administration, Oral, Animals, Pharmaceutical Preparations, Excipients, Humans, Intestinal Absorption, Lipids, Drug Design, Drug Delivery Systems, Hydrophobic and Hydrophilic Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.